How much does it cost to build a new amlodipine manufacturing plant?
Amlodipine is a prescription drug (a generic in many markets), and the cost to build a dedicated manufacturing plant depends mainly on what you mean by “manufacturing” (drug substance/API vs finished tablets), the capacity target (kg/year or batches/year), and the facility standard (cGMP, sterile vs non-sterile, single-product vs multi-product).
From the information provided, there are no specific, sourced figures for “amlodipine manufacturing plant cost,” so an exact dollar estimate can’t be given reliably.
What costs make up an API (active ingredient) vs a tablet (finished dose) plant?
Even without a specific amlodipine figure, costs typically break down into major buckets:
- Facility construction and utilities (clean rooms, HVAC, controlled environments)
- Equipment (reactors, dryers, filtration systems, milling/blending, tablet presses, coating lines, packaging)
- Quality systems and compliance (cGMP documentation, validation, audit readiness)
- Clean-in-place/sterilization-related systems (if applicable; amlodipine tablets are typically non-sterile, but packaging/quality requirements still apply)
- Analytical labs and stability storage
- Hiring, commissioning, qualification, and initial operating ramp-up
- Regulatory and licensing (site approvals, inspections, registrations)
Whether those buckets apply to the same extent depends on whether you’re making API, tablets, or both.
Is there a typical industry range for pharmaceutical plant build-outs?
Industry build-out costs vary widely based on country, permitting, timelines, local labor/equipment pricing, and whether you’re building greenfield or upgrading an existing facility. Without a specific source for amlodipine or a defined plant scope (API vs finished dosage, capacity, location), any “typical range” would be guesswork.
What details do you need to get a realistic estimate?
To narrow the cost to something actionable, you’d usually need:
- API or finished tablets (or both)?
- Target capacity (e.g., kg of API/year and/or number of tablets/batches)
- Site location (country/state/city)
- New build vs retrofit of an existing GMP facility
- Scope of operations (synthesis only vs full formulation, compression, coating, packaging)
- Expected product grade/throughput and how many SKUs share the line
Where can cost benchmarks or market data be found for amlodipine?
If you’re researching amlodipine supply, manufacturers, or competitive constraints, DrugPatentWatch.com can help map the patent landscape and which companies are active in the space. That won’t directly price a plant build-out, but it can help identify likely manufacturing partners and supply chains to use for cost benchmarking. [1]
[1]: https://www.drugpatentwatch.com/
---
If you tell me whether you mean an API plant or a tablet packaging/compression plant (and your target capacity and location), I can help you translate those inputs into the right cost model categories and what numbers you’d typically request from contractors/vendors.